Harrow, Inc.
HROW
#6206
Rank
A$1.47 B
Marketcap
A$39.26
Share price
-5.11%
Change (1 day)
-32.89%
Change (1 year)

Earnings for Harrow, Inc. (HROW)

Earnings in 2026 (TTM): -A$13.89 Million

According to Harrow, Inc.'s latest financial reports the company's current earnings are A$0.27 Billion. In 2025 the company made an earning of A$32.82 Million, an increase over its 2024 earnings that were of A$7.86 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harrow, Inc. from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$13.89 Million-142.3%
2025 A$32.82 M317.34%
2024 A$7.86 M-329.09%
2023 -A$3.44 Million-224.34%
2022 A$2.76 M3.01%
2021 A$2.68 M149.06%
2020 A$1.07 M434.29%
2019 A$0.2 M-102.68%
2018 -A$7.51 Million-57.11%
2017 -A$17.51 Million-21.93%
2016 -A$22.42 Million5.11%
2015 -A$21.33 Million46.16%
2014 -A$14.6 Million32.68%
2013 -A$11 Million42.63%
2012 -A$7.72 Million
2010 -A$3.57 Million-45.76%
2009 -A$6.57 Million21.83%
2008 -A$5.4 Million-491.97%
2007 A$1.37 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.12 Billion 664.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26.13 Million 73.81%๐Ÿ‡บ๐Ÿ‡ธ USA